¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inhibitory effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • combined effect
    º´¿ëÈ¿°ú
  • concentration effect
    ³óµµÈ¿°ú
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
  • cytopathic effect
    ¼¼Æ÷º´º¯È¿°ú
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carry-over effect
    ÀÜÈ¿
  • cavitation effect
    °øµ¿È¿°ú
  • ceiling effect
    ÃÖ°íÈ¿°ú
  • delayed effect
    Áö¿¬È¿°ú
  • detergent effect
    ¼¼Ã´È¿°ú, Á¤È­È¿°ú
  • deterministic effect
    È®Á¤ÀûÈ¿°ú
  • diabetogenic effect
    ´ç´¢º´À¯¹ßÈ¿°ú
  • dose rate effect
    ¼±·®·üÈ¿°ú
  • effect
    È¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • biologic effect
    »ý¹°ÇÐÀûÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • bridle effect
    °í»ßÈ¿°ú, Á¦¾îÈ¿°ú
  • carrier effect
    ¿î¹Ýüȿ°ú
  • carry-over effect
    ÀÜÈ¿
  • cavitation effect
    °øµ¿È¿°ú
  • ceiling effect
    ÃÖ°íÈ¿°ú
  • clasp-knife effect
    Á¢´ÂĮȿ°ú
  • cohort effect
    ÄÚȣƮȿ°ú
  • combined effect
    º´¿ëÈ¿°ú
  • concentration effect
    ³óµµÈ¿°ú
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
  • cytopathic effect
    ¼¼Æ÷º´º¯È¿°ú
  • delayed effect
    Áö¿¬È¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Purkinje effect
    Ǫ¸£Å°´Ï¿¡È¿°ú
  • RF antennae effect
    °íÁÖÆÄ ¾ÈÅ׳ª È¿°ú
  • Stiles-Crawford effect
    ½ºÅ¸ÀϽº-Å©·ÎÆ÷µåÈ¿°ú
  • T1 shortening effect
    T1 ´ÜÃà È¿°ú
  • T2 shortening effect
    T2 ´ÜÃà È¿°ú
  • Tyndall effect
    ƾ´ÞÈ¿°ú
  • additive effect
    ºÎ°¡È¿°ú
  • additive effect
    »ó°¡È¿°ú (ßÓÊ¥üùÍý)
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • air barrier effect
    °ø±â¸·È¿°ú(ÍöѨدüùÍý).
  • air gap effect
    °ø±â °£°Ý È¿°ú
  • allogeneic effect
    µ¿Á¾ÀÌÇüÈ¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ (¡­åäð¤ì×í­).
  • additive effect
    »ó°¡È¿°ú (ßÓÊ¥üùÍý)
  • additive effect
    ºÎ°¡È¿°ú
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • air barrier effect
    °ø±â¸·È¿°ú(ÍöѨدüùÍý).
  • air gap effect
    °ø±â °£°Ý È¿°ú
  • allogeneic effect
    µ¿Á¾ÀÌÇüÈ¿°ú
  • analgesic effect
    ÁøÅëÈ¿°ú.
  • antagonistic effect
    ±æÇ×È¿°ú
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
  • anticurare effect
    Ç×Å¥¶ó·¹ÀÛ¿ë.
  • antioxidant effect
    Ç×»êÈ­È¿°ú(¡­üùÍý).
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú.
  • antitussive effect
    ÁøÇØÈ¿°ú(òåú¦üùÍý).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Haldane effect
    Ȧµ¥ÀÎ È¿°ú(üùÍý)
  • heterotropic effect
    ÀÌÁú È¿°ú(ì¶òõüùÍý)
  • homoptropic effect
    µ¿Áú È¿°ú(ÔÒòõüùÍý)
  • hydrophobic effect
    ¼Ò¼ö È¿°ú(áÂâ©áÂâ©)
  • hyperchromic effect
    Èí±¤Áõ°¡ È¿°ú (ýåÎÃñòÊ¥üùÍý)
  • hypochromic effect
    Èí±¤ °¨¼Ò È¿°ú(ýåÎÃÊõá´üùÍý)
  • induction effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • inductive effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • isotope effect
    µ¿À§¿ø¼Ò È¿°ú(ÔÒêÈêªáÈüùÍý)
  • Johnston-Ogston effect
    ÁÔ½ºÅæ-¿À±×½ºÅæ È¿°ú(üùÍý)
  • kerr effect
    Äɸ£ È¿°ú(üùÍý)
  • kinetic isotope effect
    ¹ÝÀÀ¼Óµµ(ÚãëëáÜÓø) µ¿À§¿ø¼ÒÈ¿°ú(ÔÒêÈêªáÈüùÍý)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • Maxwell effect
    ¸ß½º¿¤ È¿°ú(üùÍý)
  • meiotic effect
    °¨¼öºÐ¿­ È¿°ú(Êõâ¦ÝÂÖ®üùÍý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • reverse piezoelectric effect
    ¿ª¾ÐÀüÈ¿°ú
  • RF antennae effect
    °íÁ֯ľÈÅ׳ªÈ¿°ú
  • shielding effect
    Â÷ÆóÈ¿°ú
  • siphonage effect
    ½ÎÀÌÆùÈ¿°ú
  • spatial presaturation effect
    °ø°£ÀüÆ÷È­È¿°ú
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • T1 shortening effect
    T1´ÜÃàÈ¿°ú
  • T2 shortening effect
    T2´ÜÃàÈ¿°ú
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FIC Fogarty International Center; fractional inhibitory concentration
GIFB growth hormone inhibitory factor, brain
GIP gastric inhibitory polypeptide; giant cell interstitial pneumonia; glucose-dependent insulinotropic ...
GIPR gastric inhibitory polypeptide receptor
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LOEC Lowest observed effect concentrations
ME McCollough Effect
NOAEL No Observable Adverse Effect Level
NOEL No Observable Effect Level
NOAEL No Observed Adverse Effect Level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blanching effect
    Ç¥¹é È¿°ú
  • blocking effect
    Â÷´Ü È¿°ú
  • carriar effect
    ´ãü È¿°ú
    Ha
  • carry effect
    ¿î¹Ý È¿°ú
  • cavitation effect
    °øµ¿ È¿°ú
  • clasp knife effect
    Á¢´Â Ä® È¿°ú
  • cytopathogenic effect
    ¼¼Æ÷ º¯¼º Çö»ó, ¼¼Æ÷ º´º¯ È¿°ú
  • Deelman`s effect
    µ¨¸¸ È¿°ú
  • detergent effect
    Á¤È­ ÀÛ¿ë
  • domino effect
    µµ¹Ì³ë È¿°ú
  • Donnan effect
    µµ³­ È¿°ú
  • Doppler effect
    µµÇ÷¯ È¿°ú, Doppler È¿°ú
    1. ±Ù¿øÁö¿¡ ´ëÇÑ ¼ö½ÅÁöÀÇ »ó´ëÀûÀÎ ¿îµ¿À¸·ÎºÎÅÍ ¾ß±âµÇ´Â Á֯ļöÀÇ ¸í¹éÇÑ º¯È­. 2. ¾î¶² ¹°Ã¼°¡ ¿îµ¿ »óÅ¿¡ ÀÖÀ» ¶§ ³ªÅ¸³ª´Â ¹ÝÇâµÇ´Â ¹æ»ç¼±¿¡¼­ Áøµ¿¼öÀÇ º¯È­´Â µµÇ÷¯ È¿°úÀÇ °á°úÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ¸·ÎºÎÅÍ ¶³¾îÁø ¹°Ã¼ÀÇ ¿îµ¿Àº Á¤Áö »óÅÂÀÇ ¹°Ã¼¿¡ ºñ±³ÇØ º¼ ¶§ ´õ ³·Àº Áøµ¿¼öÀÇ ¹ÝÇâÀ» ÀÏÀ¸Å³ °ÍÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ» ÇâÇÑ ¿îµ¿Àº ´õ ³ôÀº Áøµ¿¼ö¸¦ ÀÏÀ¸Å²´Ù.
  • dose rate effect
    ¼±·®À² È¿°ú
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • double effect
    ÀÌÁß È¿°ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
rebound effect The characteristic of a drug to produce reverse effects when either the effect of the drug has passed or when the patient no longer responds to the drug.
(18 Nov 1997)
Venturi effect Term applied to the operation of a Venturi tube and similar systems.
(05 Mar 2000)
mass effect <neurology> Damage to the brain due the bulk of a tumour, the blockage of fluid or excess accumulation of fluid within the skull.
(16 Dec 1997)
red drop effect Experimental observation that the photosynthetic efficiency of monochromatic light is greatly reduced above 680 nm, even though chlorophyll absorbs well up to 700 nm. Led to the discovery of the two light reactions of photosynthesis.
See: photosystems I and II.
(18 Nov 1997)
gibbs-donnan effect The observation that charged molecules starting on one side of a semipermeable membrane sometimes will not evenly distribute themselves by diffusion on both sides of the membrane. This effect is probably because there are other charged substances already present which cannot move through the membrane themselves and which are creating an electric field that influences the movement of the incoming charged molecules.
(09 Oct 1997)
maternal effect gene Gene, usually required for early embryonic development, whose product is secreted into the egg by the mother. The phenotype is thus determined by the mother's, rather than the egg's, genotype.
Compare:. Zygotic effect gene.
See: egg polarity gene.
(18 Nov 1997)
Pasteur effect <biochemistry> Decrease in the rate of carbohydrate breakdown that occurs in yeast and other cells when switched from anaerobic to aerobic conditions. Results from a relatively slow flux of material through the biochemical pathways of respiration compared with those of fermentation.
(18 Nov 1997)
Pasteur's effect The inhibition of fermentation by oxygen, first observed by Pasteur; either not observed, or only slightly observed, in malignant tumours.
Compare: Crabtree effect.
(05 Mar 2000)
glucose effect <biochemistry> The ability of the sugar glucose to block sugar metabolism by keeping the genes which make the enzymes involved in the early steps of sugar metabolism from making those enzymes.
(09 Oct 1997)
greenhouse effect The effect of certain gases in the Earth's atmosphere in trapping heat from the sun.
(05 Dec 1998)
Rivero-Carvallo effect Inspiratory increase in the systolic murmur of tricuspid insufficiency; the characteristic distinguishing tricuspid insufficiency from mitral insufficiency.
(05 Mar 2000)
Circe effect An effect observed in enzyme catalysis in which accelerated diffusion of the substrate occurs through attractive forces of the enzyme's active site.
(05 Mar 2000)
Russell effect The ability of an agent, other than light, to make a developable latent image in a photographic film emulsion.
Synonym: Russell effect.
(05 Mar 2000)
clasp-knife effect Initial increased resistance to stretch of the extensor muscles of a joint that give way rather suddenly allowing the joint then to be easily flexed; the rigidity is due to an exaggeration of the stretch reflex.
See: lengthening reaction.
Synonym: clasp-knife effect, clasp-knife rigidity.
(05 Mar 2000)
photechic effect The ability of an agent, other than light, to make a developable latent image in a photographic film emulsion.
Synonym: Russell effect.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á